Research Outline

Pharma Oncology Companies Competitive Landscape

Goals

To provide an overview of the top oncology companies including: markets served, upcoming oncology drugs in the company pipeline, examples of company partnerships, any recent mergers/acquisitions within the company, and key corporate missions and messages they convey in the market for the top five pharma oncology companies that were previously identified.

Early Findings

To make research more organized, and easier to work with, a spreadsheet has been created and populated with markets served, upcoming oncology drugs in the company pipeline, examples of company partnerships, any recent mergers/acquisitions within the company, and key corporate missions and messages they convey in the market.
  • The spreadsheet may be viewed here.
  • Information for Roche from previous research was completed and new information added.
  • Research began on Celgene and was also entered into the spreadsheet, but time did not allow it to be finished.
  • Please note that with the acquisition of Celgene, by Bristol-Myers Squibb that there could be some duplicate information. If this is the case, it will cut down on research time.